Important Update: Compounded Tirzepatide Phasing Out!
The FDA has recently announced a significant change in the availability of compounded tirzepatide, a medication known for its benefits in treating type 2 diabetes and supporting weight loss efforts. This update comes as the national shortage of tirzepatide injections, which began in 2022, has been resolved.
Key Points to Know
Shortage Resolution: The FDA has confirmed that Eli Lilly, the manufacturer of tirzepatide, now has the capacity to meet both current and projected demand for the drug
Phasing Out Timeline: Compounded tirzepatide will no longer be available after March 19, 2025
Transition Periods:
503A pharmacies: Until February 18, 2025
503B facilities: Until March 19, 2025
What This Means for You
If you're currently using compounded tirzepatide, it's crucial to take action:
Consult Your Healthcare Provider: Schedule an appointment as soon as possible to discuss your treatment options
Transition Planning: Talk about switching to FDA-approved, commercially available versions of tirzepatide, such as Mounjaro or Zepbound
Ensure Continuous Treatment: Plan ahead to avoid any interruptions in your medication regimen
Stay Informed: Remember that this information may be subject to change based on demand and future FDA decisions
Alternative Options
For those who may need to explore other options, there are several FDA-approved alternatives to consider:
Wegovy (semaglutide): Approved for weight management in adults and children 12 and older
Ozempic (semaglutide): Used for type 2 diabetes management
Victoza (liraglutide): Approved for type 2 diabetes in adults and children 10 and older
Each of these medications has its own benefits and potential side effects, so it's essential to discuss them thoroughly with your healthcare provider. At Candescent Health and Wellness, we are committed to following the guidance and regulations of the FDA while ensuring the best possible care for our patients. We understand that this change may cause concern for some, but we're here to support you through this transition. Remember, your health journey is unique, and we're here to help you navigate these changes. Don't hesitate to reach out if you have any questions or concerns about your treatment plan.